Yes. Samsung Biologics (207940.KS) passes the AAOIFI Shari’ah Standard 21 screen.
Not settled. Samsung Biologics (207940.KS) could not be confirmed either way under the Catholic screen based on the USCCB investment guidelines.
Yes. Samsung Biologics (207940.KS) passes the Biblically Responsible Investing (BRI) screen.